9th Circ. Urged To Reinstate Expert In Novartis Jaw Injury Suit
Law360, New York (February 4, 2014, 5:58 PM EST) -- Two former users of Novartis Pharmaceuticals Corp. bone drugs Aredia and Zometa urged the Ninth Circuit on Monday to allow expert testimony that the medications caused their jaw injuries and to revive their lawsuits against the drugmaker.
Lower courts were wrong to exclude the testimony of Dr. Richard Jackson, who concluded that plaintiffs Duane Luttrell and Linda Messick suffered from osteonecrosis of the jaw caused by their use of the bisphosphonates Aredia and Zometa, according to attorneys for the duo. The courts, in rulings in separate suits filed by the two plaintiffs, determined his testimony was unreliable under the Daubert evidentiary...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!